NanoViricides Inc. (NNVC)

[KuChing]

Patents, Patents, Patents

For bio-tech companies, it’s all about patents. I believe the recent run up is due, in part, to the latest health care bill that extends the life of revenue for patented, FDA approved, drugs. Under recently passed health care bill, there are provisions for bio-tech companies, like NanoViricides (NNVC) that have exclusive rights to patents or have outright patents for new drug pipelines that now have 2 ½ times more time (12 years Vs 5 years) to sell their product before generic competition starts. Time = Money.

NNVC has the perfect business model for the new healthcare bill. At a minimum, the value of NNVC was multiplied by 2.5. Multiply that by the number of viruses NNVC attacks (HIV, Type A Flu, Herpes Simplex 1 and 2, EKC, Rabbies, Dengue Fever, Ebola,). Let’s see, 9x 2.5x1.0 PPS >= $20. That’s without new any new deals.

That’s just simplistic math. There is some real money behind this run up…..